Pathology Review: Dermatopathology, Hematopathology, and Breast for the General Pathologist – A Video CME Teaching Activity
- Differentiate spongiotic, psoriasis form and interface dermatitis.
- Discuss squamous basal cell carcinoma and their stimulators.
- Achieve a better understanding of histologic and molecular correlations in melanocytic neoplasms.
- Review myeloid neoplasms and WHO revised diagnostic criteria.
- Identify inflammatory and reactive lesions of the breast.
- Discuss molecular classification of breast cancer and molecular prognostic factors.
- Analyze post-neoadjuvant breast specimens.
- Identify benign and neoplastic lymphoid disorders in blood and bone marrow.
- Describe cutaneous vascular tumors.
- Discuss non-epithelial lesions of the breast.
- Review the spectrum of triple negative breast neoplasia problems in interpretation of breast core needle biopsies.
- Review cutaneous adnexal neoplasms.
Session 1Pathologic Examination of the Neoadjuvant Specimen
Mara H. Rendi, M.D., Ph.D.
The Low Grade Breast Neoplasia Pathway
Mara H. Rendi, M.D., Ph.D.
Session 2
A Brief Tour Through Benign Adnexal Neoplasms
Philip E. LeBoit, M.D.
Adnexal Carcinoma
Philip E. LeBoit, M.D.
Session 3
WHO and Beyond
Kathryn Foucar, M.D.
Overview of Classification Myeloid Neoplasms
Kathryn Foucar, M.D.
Session 4
Acute Myeloid Leukemia: Key Strategies
Kathryn Foucar, M.D.
Practical Approach to Myelodysplasia
Kathryn Foucar, M.D.
Session 5
Molecular Classification of Breast Cancer and Prognostic Testing
Mara H. Rendi, M.D., Ph.D.
Updates on the 8th Edition of the AJCC Staging Manual for Breast Cancer
Mara H. Rendi, M.D., Ph.D.
Session 6
Spindle Cell Lesions in the Breast
Mara H. Rendi, M.D., Ph.D.
Session 7
Benign and Neoplastic Lymphoid Disorders in Blood and Bone Marrow with Interactive Case Presentation
Kathryn Foucar, M.D.
Session 8
Cutaneous Vascular Tumors
Philip E. LeBoit, M.D.
Special Type Breast Cancers
Mara H. Rendi, M.D., Ph.D.
Session 9
Spongiotic, Psoriasiform and Interface Dermatitis with Cases
Philip E. LeBoit, M.D.
From Nevus to Melanoma: How Melanocytes Become Malignant, Morphologically and Molecularly
Philip E. LeBoit, M.D.
Session 10
Squamous and Basal Cell Carcinoma: The Cutting Edge
Philip E. LeBoit, M.D.
Reviews
There are no reviews yet.